UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients

Annals of the rheumatic diseases, 2021-09, Vol.80 (9), p.e147-e147

2021

Volltextzugriff (PDF)

Panniculitis on the trunk as a possible characteristic feature of anti‐SAE1/2 antibody‐positive dermatomyositis: A possible cutaneous manifestation of treatment resistance

Journal of dermatology, 2024-07, Vol.51 (7), p.e227-e228

2024

Volltextzugriff (PDF)

Successful combination therapy of bimekizumab and granulocyte monocyte adsorption apheresis for generalized pustular psoriasis complicated with microscopic polyangiitis

Journal of dermatology, 2023-06, Vol.50 (6), p.e181-e182

2023

Volltextzugriff (PDF)

Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone

Journal of dermatology, 2023-07, Vol.50 (7), p.e206-e207

2023

Volltextzugriff (PDF)

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab

Journal of dermatology, 2020-06, Vol.47 (6), p.e217-e219

2020

Volltextzugriff (PDF)

A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on “Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody”

Journal of dermatology, 2023-01, Vol.50 (1), p.e39-e40

2023

Volltextzugriff (PDF)

Comment on: Successful treatment of rapid progressive interstitial lung disease in a case of anti‐Zo antibody positive anti‐synthetase syndrome

International journal of rheumatic diseases, 2023-09, Vol.26 (9), p.1872-1873

2023

Volltextzugriff (PDF)

Anti‐Mi‐2 antibody titers and cutaneous manifestations in dermatomyositis

Journal of cutaneous immunology and allergy, 2019-04, Vol.2 (2), p.49-52

2019

Volltextzugriff (PDF)

Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits

Journal of cutaneous immunology and allergy, 2020-10, Vol.3 (5), p.120-121

2020

Volltextzugriff (PDF)

ANCA‐associated neuropathy in systemic sclerosis: A case report and review of literature

Journal of cutaneous immunology and allergy, 2021-04, Vol.4 (2), p.34-36

2021

Volltextzugriff (PDF)

Correlation of serum allergen-specific IgE with total serum IgE and IgE specific to other allergens in Atopic dermatitis patients

Journal of the European Academy of Dermatology and Venereology, 2024-09, Vol.38 (9), p.e761

2024

Volltextzugriff (PDF)

Comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients

Clinical and experimental rheumatology, 2023-01, Vol.41 (1), p.195

2023

Volltextzugriff (PDF)

Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera

Journal of autoimmunity, 2021-08, Vol.122, p.102680, Article 102680

2021

Volltextzugriff (PDF)

Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy

Clinica chimica acta, 2017-08, Vol.471, p.304-307

2017

Volltextzugriff (PDF)

Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA

Clinical and Experimental Rheumatology, 2022-02, Vol.40 (2), p.219-223

2022

Volltextzugriff (PDF)

Keratinocyte derived extracellular vesicles mediated crosstalk between epidermis and dermis in UVB-induced skin inflammation

Cell communication and signaling, 2024-09, Vol.22 (1), p.461-13, Article 461

2024

Volltextzugriff (PDF)

Clinical and serological features of dermatomyositis and systemic lupus erythematosus patients with autoantibodies to ADAR1

Journal of dermatological science, 2020-10, Vol.100 (1), p.82-84

2020

Volltextzugriff (PDF)

Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis

Journal of dermatological science, 2019-10, Vol.96 (1), p.50-52

2019

Volltextzugriff (PDF)

803 Plasmacytoid Dendritic Cells are Not Major Producers of Type 1 Interferons in Cutaneous Lupus

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A56-A59

2022

Volltextzugriff (PDF)

Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA

Clinical and experimental rheumatology, 2022-02, Vol.40 (2), p.219

2022

Volltextzugriff (PDF)

Response to: ‘Anti-Ku antibodies: important points to consider’ by Mahler et al

Annals of the rheumatic diseases, 2021-11, Vol.80 (11), p.e183-e183

2021

Volltextzugriff (PDF)

Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles

Immunological medicine, 2024-10, p.1

2024

Volltextzugriff (PDF)

Two novel anti-aminoacyl tRNA synthetase antibodies: Autoantibodies against cysteinyl-tRNA synthetase and valyl-tRNA synthetase

Autoimmunity reviews, 2022-12, Vol.21 (12), p.103204, Article 103204

2022

Volltextzugriff (PDF)

Multiplexed Mass Cytometry of Cutaneous Lupus Erythematosus and Dermatomyositis Skin: An In-depth, B-Cell–Directed Immunoprofile

Journal of investigative dermatology, 2024-08

2024

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(42)
Berichte
(5)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients

Panniculitis on the trunk as a possible characteristic feature of anti‐SAE1/2 antibody‐positive dermatomyositis: A possible cutaneous manifestation of treatment resistance

Successful combination therapy of bimekizumab and granulocyte monocyte adsorption apheresis for generalized pustular psoriasis complicated with microscopic polyangiitis

Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab

A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1‐γ ELISA results: Comment on “Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody”

Comment on: Successful treatment of rapid progressive interstitial lung disease in a case of anti‐Zo antibody positive anti‐synthetase syndrome

2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases

Anti‐Mi‐2 antibody titers and cutaneous manifestations in dermatomyositis

Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits

ANCA‐associated neuropathy in systemic sclerosis: A case report and review of literature

Correlation of serum allergen-specific IgE with total serum IgE and IgE specific to other allergens in Atopic dermatitis patients

Comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients

Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera

Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy

Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA

Keratinocyte derived extracellular vesicles mediated crosstalk between epidermis and dermis in UVB-induced skin inflammation

Clinical and serological features of dermatomyositis and systemic lupus erythematosus patients with autoantibodies to ADAR1

Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis

803 Plasmacytoid Dendritic Cells are Not Major Producers of Type 1 Interferons in Cutaneous Lupus

Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA

Response to: ‘Anti-Ku antibodies: important points to consider’ by Mahler et al

Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles

Two novel anti-aminoacyl tRNA synthetase antibodies: Autoantibodies against cysteinyl-tRNA synthetase and valyl-tRNA synthetase

Multiplexed Mass Cytometry of Cutaneous Lupus Erythematosus and Dermatomyositis Skin: An In-depth, B-Cell–Directed Immunoprofile

Suchergebnisse filtern